ciprofloxacin

Generic: ciprofloxacin

Labeler: direct rx
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name ciprofloxacin
Generic Name ciprofloxacin
Labeler direct rx
Dosage Form TABLET, COATED
Routes
ORAL
Active Ingredients

ciprofloxacin hydrochloride 250 mg/1

Manufacturer
Direct Rx

Identifiers & Regulatory

Product NDC 72189-323
Product ID 72189-323_2c3d4146-03d9-30a9-e063-6294a90ad471
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA208921
Listing Expiration 2026-12-31
Marketing Start 2022-02-21

Pharmacologic Class

Classes
cytochrome p450 1a2 inhibitors [moa] fluoroquinolone antibacterial [epc] fluoroquinolones [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 72189323
Hyphenated Format 72189-323

Supplemental Identifiers

RxCUI
197511
UNII
4BA73M5E37

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name ciprofloxacin (source: ndc)
Generic Name ciprofloxacin (source: ndc)
Application Number ANDA208921 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 250 mg/1
source: ndc
Packaging
  • 6 TABLET, COATED in 1 BOTTLE (72189-323-06)
source: ndc

Packages (1)

Ingredients (1)

ciprofloxacin hydrochloride (250 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2c3d4146-03d9-30a9-e063-6294a90ad471", "openfda": {"unii": ["4BA73M5E37"], "rxcui": ["197511"], "spl_set_id": ["d88a22f4-2f61-17f2-e053-2995a90acd14"], "manufacturer_name": ["Direct Rx"]}, "finished": true, "packaging": [{"sample": false, "description": "6 TABLET, COATED in 1 BOTTLE (72189-323-06)", "package_ndc": "72189-323-06", "marketing_start_date": "20220221"}], "brand_name": "CIPROFLOXACIN", "product_id": "72189-323_2c3d4146-03d9-30a9-e063-6294a90ad471", "dosage_form": "TABLET, COATED", "pharm_class": ["Cytochrome P450 1A2 Inhibitors [MoA]", "Fluoroquinolone Antibacterial [EPC]", "Fluoroquinolones [CS]"], "product_ndc": "72189-323", "generic_name": "CIPROFLOXACIN", "labeler_name": "Direct Rx", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "CIPROFLOXACIN", "active_ingredients": [{"name": "CIPROFLOXACIN HYDROCHLORIDE", "strength": "250 mg/1"}], "application_number": "ANDA208921", "marketing_category": "ANDA", "marketing_start_date": "20220221", "listing_expiration_date": "20261231"}